BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14559073)

  • 1. Dysregulation of apoptosis in scorpion envenomed children: its reflection on their outcome.
    Meki AR; Hasan HA; El-Deen ZM; Bakkar S
    Toxicon; 2003 Sep; 42(3):229-37. PubMed ID: 14559073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial injury in scorpion envenomed children: significance of assessment of serum troponin I and interleukin-8.
    Meki AR; El-Deen ZM; El-Deen HM
    Neuro Endocrinol Lett; 2002 Apr; 23(2):133-40. PubMed ID: 12011799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial injury induced by scorpion sting envenoming and evidence of oxidative stress in Egyptian children.
    Ahmed AE; Hassan MH; Rashwan NI; Sayed MM; Meki AMA
    Toxicon; 2018 Oct; 153():72-77. PubMed ID: 30171930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of assessment of serum cardiac troponin I and interleukin-8 in scorpion envenomed children.
    Meki AR; Mohamed ZM; Mohey El-deen HM
    Toxicon; 2003 Feb; 41(2):129-37. PubMed ID: 12565731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of some vasoactive mediators in scorpion envenomed children: Possible relation to envenoming outcome.
    El-DeeK SE; Sayed AA; Nassar AY; Mohey-Eldeen ZM; Eldeeb HM; Meki AM
    Toxicon; 2017 Mar; 127():77-84. PubMed ID: 28088475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-1beta, interleukin-6, nitric oxide and alpha1-antitrypsin in scorpion envenomed children.
    Meki AR; Mohey El-Dean ZM
    Toxicon; 1998 Dec; 36(12):1851-9. PubMed ID: 9839669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of IL-6 and its soluble receptor, TNF-alpha and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome.
    Abdel-Haleem AH; Meki AR; Noaman HA; Mohamed ZT
    Toxicon; 2006 Mar; 47(4):437-44. PubMed ID: 16466762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sFas and sFas ligand and pediatric sepsis-induced multiple organ failure syndrome.
    Doughty L; Clark RS; Kaplan SS; Sasser H; Carcillo J
    Pediatr Res; 2002 Dec; 52(6):922-7. PubMed ID: 12438671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.
    Papathanassoglou ED; Moynihan JA; Vermillion DL; McDermott MP; Ackerman MH
    Shock; 2000 Aug; 14(2):107-12. PubMed ID: 10947151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma.
    Mouawad R; Khayat D; Soubrane C
    Melanoma Res; 2000 Oct; 10(5):461-7. PubMed ID: 11095407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scorpion sting envenomation in children in southeast Turkey.
    Bosnak M; Ece A; Yolbas I; Bosnak V; Kaplan M; Gurkan F
    Wilderness Environ Med; 2009; 20(2):118-24. PubMed ID: 19594203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer.
    Hamed EA; Zakhary MM; Maximous DW
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):999-1009. PubMed ID: 22362301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients.
    Lapinski TW; Kowalczuk O; Prokopowicz D; Chyczewski L
    World J Gastroenterol; 2004 Dec; 10(24):3650-3. PubMed ID: 15534924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis.
    Musiał K; Zwolińska D
    Apoptosis; 2011 Jul; 16(7):653-9. PubMed ID: 21516345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns.
    Yamada Y; Endo S; Nakae H; Makabe H; Sato N; Wakabayashi G; Kitamura M; Inada K; Sato S
    Burns; 2003 Dec; 29(8):799-802. PubMed ID: 14636754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.
    Yasuda N; Gotoh K; Minatoguchi S; Asano K; Nishigaki K; Nomura M; Ohno A; Watanabe M; Sano H; Kumada H; Sawa T; Fujiwara H
    Respir Med; 1998 Aug; 92(8):993-9. PubMed ID: 9893764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
    Wang CY; Zhong WB; Chang TC; Tsai YF
    Metabolism; 2002 Jun; 51(6):769-73. PubMed ID: 12037733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
    Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.